CA
VTYX

Clearstead Advisors’s Ventyx Biosciences VTYX Stock Holding History

Clearstead Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$4.51K – 2845
2025
Q4 		$4.51K Hold
500
– – ﹤0.01% 2037
2025
Q3 		$1.55K Sell
500
-315
-39% -$835 ﹤0.01% 2529
2025
Q2 		$1.75K Buy
815
+315
+63% +$509 ﹤0.01% 2353
2025
Q1 		$575 Hold
500
– – ﹤0.01% 2054
2024
Q4 		$1.09K Hold
500
– – ﹤0.01% 1909
2024
Q3 		$1.09K Hold
500
– – ﹤0.01% 1906
2024
Q2 		$1.16K Hold
500
– – ﹤0.01% 1886
2024
Q1 		$2.06K Hold
500
– – ﹤0.01% 1305
2023
Q4 		$1.24K Sell
500
-500
-50% -$4.75K ﹤0.01% 1373
2023
Q3 		$34.7K Buy
1,000
+500
+100% +$17.3K ﹤0.01% 939
2023
Q2 		$16.4K Buy
+500
New +$17.2K ﹤0.01% 922

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clearstead Advisors's VTYX Position: Q1 2026 in Review

Clearstead Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 500 shares — an estimated $4.51K sold.

Clearstead Advisors first reported a position in VTYX in Q2 2023 and held it in 11 quarters. The position peaked at $34.7K in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Clearstead Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 500 Ventyx Biosciences shares in Q1 2026, an estimated $4.51K.
  • Clearstead Advisors first reported a position in Ventyx Biosciences in Q2 2023 and held it in 11 quarters.
  • Clearstead Advisors's Ventyx Biosciences position peaked at $34.7K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.